Ranked above it

Care Bare Rx
Tells you exactly what you're buying — but $199 is a starting point, not a rate.
#1 on our tirzepatide provider ranking, above Pallas Health at #15.
Read the Care Bare Rx review →
Provider review
Its privacy policy details what goes to two AI vendors, and omits the ad pixel.
A Meta pixel fires on all 130 of its pages including the health intake and the patient portal, while the policy's visible text names Anthropic and OpenAI field by field and contains not one occurrence of Meta, Google, pixel, advertising or cookie.
Reviewed by Marcus Webb
Transparency scorecard
2 of 4 disclosed openly
What Pallas Health discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Not disclosed
Does not name a pharmacy or state a regulatory category anywhere on its own site.
State coverage published
Disclosed
Publishes which states it actually serves.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
Ranked above it

Care Bare Rx
Tells you exactly what you're buying — but $199 is a starting point, not a rate.
#1 on our tirzepatide provider ranking, above Pallas Health at #15.
Read the Care Bare Rx review →What this price covers
Medication
Included
Provider visits
Not confirmed
Shipping
Not confirmed
Lab work
Not confirmed
Coaching
Not confirmed
The catch — Its per-month averages divide the 12-week charge by three, but twelve weeks is 84 days and a year holds 4.35 of them, not four. So $597 every 12 weeks is $2,596 a year rather than the $2,388 that "$199/mo" implies, and $897 is $3,900 rather than $3,588 — about $208 and $312 a year more than the advertised averages. Pallas does disclose the mechanism in fine print: "'Per-month average' prices reflect a 12-week renewal price spread across three months."
See plans at Pallas HealthPrices read from Pallas Health's own site · August 2026
What they advertise
"Compounded semaglutide injection is $139 for your first month, then $597 every 12 weeks ($199/mo average); compounded tirzepatide injection is $179 for your first month, then $897 every 12 weeks ($299/mo average)." NAD+ nasal $79 then $567 every 12 weeks; NAD+ injection $89 then $597. Brand-name cash prices: Zepbound $1,069, Ozempic $1,299, Wegovy $1,349, Mounjaro $1,349.
What you actually pay
$216.32/mo compounded semaglutide and $325.02/mo compounded tirzepatide. Those are its own 12-week charges converted to real calendar months — $2,596 and $3,900 a year respectively.
Money you will meet later
Pallas Health (Brentmoor, Inc.) sells compounded semaglutide and tirzepatide plus NAD+, alongside brand-name GLP-1s at cash prices, and its disclosure is genuinely strong in places: six pharmacies named with phone numbers, a named prescriber group, all 50 states with the seven that need a video visit called out, a LegitScript seal that resolves, and no savings claim anywhere for arithmetic to contradict. It also bills every 12 weeks rather than monthly, which it discloses in fine print — but the "$199/mo" and "$299/mo" averages it leads with divide by three, and twelve weeks is not three months. The real cost is $216 and $325 a month. The larger problem is a privacy policy that describes exactly which fields reach Anthropic and OpenAI while never mentioning the advertising pixel running on its intake funnel.
Pallas Health appears on our tirzepatide provider ranking, our semaglutide provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
Pallas Health does not name the pharmacy that fills your prescription.
Named, six of them. Its clinical disclosures page names Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub and Foothills, each with a phone number — fuller disclosure than most providers here give. It explains the 503A and 503B categories generically but ties no pharmacy to one, and gates the actual license numbers behind an email request. One of the six, Belmar Pharma Solutions, has a March 2023 FDA warning letter on its record over section 503A violations, which FDA closed out that October.
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
All 50 states plus DC, with no exclusions, and seven states — Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota and West Virginia — plus DC requiring a video visit first. No contradictions across its 51 state pages.
The part they would rather you skipped
Pallas Health's privacy policy is unusually specific in one direction and silent in the other. Its visible text names Anthropic and OpenAI and describes, field by field, what reaches them — your chat messages, attached photos, and the meal, dose, symptom, weight and mood entries the assistant reads to answer you. That level of detail proves the company knows how to write this section. The same document contains zero occurrences of Meta, Facebook, pixel, Google, Analytics, advertising or cookie. Meanwhile a Meta advertising pixel fires on all 130 pages of the site, including the weight-loss intake funnel and the patient portal, alongside Google Analytics and an affiliate tracker — and the word "cookie" appears on none of those 130 pages, with no consent banner anywhere. Sending health-intake traffic to an advertising network without disclosing it is the same fact pattern regulators have already acted on twice in this industry. Around it: an "As seen in Forbes Health" badge appears only on the affiliate landing page and nowhere in the 130-page site, and its href points back to Pallas's own funnel rather than to Forbes; and a "200,000+ patients" and "4.8 from 2,400+ reviews" claim sits alongside its own clinical page describing a July 2026 launch with waitlist patients.
None of this is unique to Pallas Health — the whole category shares it.
The providers we rank on our tirzepatide provider ranking — the most specific board Pallas Health sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the bottom line.





128 more providers rank on our tirzepatide provider ranking — see the full ranking. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.
Ready to get started?
Prices and plans in this category change often — check Pallas Health's current pricing before you decide. Ours was read from their own site in August 2026.
Facts on this page reflect Pallas Health's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Pallas Health's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.
Pallas Health
2 compounds from $216/mo